Skip to main content

Peer Review reports

From: Activated TRPA1 plays a therapeutic role in TMZ resistance in glioblastoma by altering mitochondrial dynamics

Original Submission
30 Apr 2022 Submitted Original manuscript
28 May 2022 Reviewed Reviewer Report - Pabitra Bikash Pal
29 May 2022 Reviewed Reviewer Report
20 Jun 2022 Author responded Author comments - Bin Zhang
Resubmission - Version 2
20 Jun 2022 Submitted Manuscript version 2
22 Jun 2022 Author responded Author comments - Bin Zhang
Resubmission - Version 3
22 Jun 2022 Submitted Manuscript version 3
25 Jun 2022 Author responded Author comments - Bin Zhang
Resubmission - Version 4
25 Jun 2022 Submitted Manuscript version 4
27 Jun 2022 Author responded Author comments - Bin Zhang
Resubmission - Version 5
27 Jun 2022 Submitted Manuscript version 5
28 Jun 2022 Author responded Author comments - Bin Zhang
Resubmission - Version 6
28 Jun 2022 Submitted Manuscript version 6
3 Aug 2022 Reviewed Reviewer Report - Pabitra Bikash Pal
3 Aug 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
5 Aug 2022 Editorially accepted
19 Aug 2022 Article published 10.1186/s12860-022-00438-1

You can find further information about peer review here.

Back to article page